Nattokinase
Supplements · Cardiovascular & Anti-Inflammatory Herbs · Supplement, Typed Supps
An enzyme purified from a traditional Japanese fermented soybean food, studied for supporting healthy circulation and clot breakdown.
Stage by stage
- Intake (Enteric-coated capsule): Taken to survive stomach acid before absorption.
- Small intestine (Absorbed): Enzyme absorbed into the bloodstream.
- Bloodstream (Circulates): Reaches the coagulation and fibrinolytic system.
- Clotting proteins (Fibrin & PAI-1): Breaks down fibrin directly and inhibits PAI-1, the brake on the body’s clot-clearing system.
What the evidence supports
- Improving fibrinolysis and circulation-related markers — limited evidence. Small human trials and lab studies show nattokinase increases fibrinolytic activity and modestly improves markers like blood pressure and blood viscosity, but trials are generally small, short, and not consistently placebo-controlled, so it falls short of proof for hard cardiovascular outcomes like preventing heart attack or stroke.
- Reducing blood pressure modestly — limited evidence. A few small randomized trials found modest systolic blood pressure reductions with nattokinase, but the evidence base is thin and hasn't been replicated at scale.
- Evidence on Increased bleeding risk, especially combined with anticoagulant or antiplatelet drugs — moderate evidence. Nattokinase inhibits PAI-1 and enhances fibrin breakdown, mechanisms that plausibly and, in small reports, practically add to the effect of warfarin, aspirin, clopidogrel and similar drugs. Large randomized safety trials quantifying excess bleeding are lacking, but case reports and mechanistic data are consistent enough that major integrative-medicine references (e.g., Memorial Sloan Kettering) advise caution or avoidance with these combinations.
Typical dose
2,000 FU (roughly 100 mg) once or twice daily is most common in retail products; some clinical research has used higher doses up to about 10,800 FU daily.
Upper limit: No established UL; the FDA has not granted nattokinase GRAS status and there's no official maximum dose.
Timing
Often taken on an empty stomach to protect enzyme activity.
Time to effect
- Unclear: No validated human time-to-effect exists for cardiovascular outcomes; lab fibrinolytic changes are seen within hours but haven’t been tied to a clinical timeline.
Common myth
“Nattokinase is a safe, natural alternative to blood-thinning medication.” In reality: It has a real, mechanistically distinct effect on clot breakdown, but it hasn’t been tested head-to-head against prescription anticoagulants, and combining the two raises genuine bleeding-risk concerns rather than offering a gentler substitute.
Food sources
More in Cardiovascular & Anti-Inflammatory Herbs
In the glossary
Sources